The new chief executive of China National Bluestar said he was conducting a review of its operations that could include divestments in a bid to boost growth and competitiveness at the unit of state-owned China National Chemical Corporation (ChemChina).
Start your deal-making journey now!
Subscribe now to enjoy unlimited access at just $59.
Premium coverage on private equity, venture capital, and startups in Asia.
Exclusive scoops from our reporters in nine key markets.
In-depth interviews with industry leaders shaping the ecosystem.
Already a Subscriber? Log in
Contact us for corporate subscriptions at subs@dealstreetasia.com
